Skip to content

Effect of Timing of Oocyte Denudation Before ICSI in an Oocyte Donation Model

Effect of Timing of Oocyte Denudation Before ICSI and Its Results in an Oocyte Donation Model: a Cluster Randomized Controlled Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03121924
Enrollment
375
Registered
2017-04-20
Start date
2015-12-01
Completion date
2019-08-01
Last updated
2020-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fertility

Keywords

oocyte denudation, preincubation, icsi, oocyte donation

Brief summary

Analyze the effect of preincubation time of oocyte on the results of ICSI in a oocyte donation model.

Detailed description

There is an intense communication inside the follicular structure. Bidirectional information between the oocyte and the granulosa cells is needed for a normal follicular development and oocyte competence. There are conflicting results on the effect of pre-incubation time in ICSI. It is not clear the proper time to denudate the oocyte from the somatic cells prior to ICSI, and some authors describe a negative impact of the premature cummulus removal on the ICSI results. The aim of this study is to investigate wheter a preincubation time between oocyte retireval and injection has any effect on the ICSI ( intracytoplasmatic sperm injection) results .

Interventions

PROCEDUREtiming for oocyte denudation and Intracytoplasmatic Sperm injection

Donated oocytes were randomly allocated to two groups concerning the time of cumulus corona removal. The first group: After oocyte retrieval, cumulus cells were immediately removed and then ICSI was performed; in the second group, the oocyte-cumulus complexes were incubated for 4 hours. Afterwards, the granulosa cells were removedand ICSI was immediately performed.

Sponsors

Hospital Italiano de Buenos Aires
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 32 Years
Healthy volunteers
Yes

Inclusion criteria

* Oocytes retrieved from healthy donors, younger than 32 years old , with proven maternity(preference), who meet the admission criteria of ovodonation program: * The oocytes included will be the product of antagonist stimulation protocol and with Gnrh agonists trigger. (see annex) * Healthy women under 50 years of age , who meet the criteria as receptors into the ovodonation program. * Oocytes retrieved after 36.5 h + -1 h of administration of triptorelin acetate. * Only mature oocytes, in stage MII, will be included and injected. * Use of fresh or thawed semen for the ICSI.

Exclusion criteria

* Cases of severe male factor such as azoospermia or severe oligo-astheno-teratospermia( alone or combinated) * Sperm samples from surgical procedures (biopsy / testicular or epididymal puncture) * Donors with a polycystic ovarian profile, according to The Androgen Excess and PCOS Society (AES), 2006. * Thawed donated oocytes * Oocytes from patients who have previously donated within a period of less than three months. * Donors whith poor response (oocyte retrieved less than \< 4 oocytes). * Suspicion or signs of Endometriosis in donor patient.

Design outcomes

Primary

MeasureTime frameDescription
Number of M2 oocytes at injectionfour hours after oocyte retrievalAsessment of the number of M2 oocytes was made after the oocyte denudation and ICSI
Number of normal fertilized oocytes after ICSI24 hoursAsessment of the normal fertilization rate was made 24 hours after the intervention.
Number of cleaving embryos72 hoursThe embryo cleavage was evaluated after 48 hours and 72 hours after the ICSI was performed.
Number of TOP embryos72 hoursThe embryos were morfologically classified into 4 categories . It considered TOP embryos those correctly fertilized at day 1, and with regular 6 to 8 cells at day 2 with less than 20% fragmentation and without multinuclear blastomeres.

Secondary

MeasureTime frameDescription
Implantation rate14 days after embryo trasferThe implantation rate was the ratio between the number of gestacional sacs and the number of transferred embryos.
Clinical pregnancy rate6 to 7 weekClinical pregnancy is confirmed by ultrasonography ,when one or more gestational sacs with heart activity are seen.

Countries

Argentina

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026